Spero Therapeutics Inc. (SPRO) at a glance

Spero Therapeutics Inc. (SPRO) is a Healthcare company. It trades at $2.94. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Momentum (72/100) and its weakest is Income (40/100).

Price
$2.94
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.80 to $3.22
Vestovix Score52/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
72